ProShare Advisors
AGN

ProShare Advisors’s Allergan plc AGN Stock Holding History

ProShare Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-34,101
Closed -$6.04M – 1697
2020
Q1 		$6.04M Sell
34,101
-23,621
-41% -$4.45M 0.04% 320
2019
Q4 		$11M Buy
57,722
+11,851
+26% +$2.14M 0.05% 336
2019
Q3 		$7.72M Buy
45,871
+5,408
+13% +$881K 0.04% 353
2019
Q2 		$6.78M Sell
40,463
-8,509
-17% -$1.18M 0.04% 364
2019
Q1 		$7.17M Buy
48,972
+1,596
+3% +$231K 0.04% 358
2018
Q4 		$6.33M Buy
47,376
+933
+2% +$153K 0.04% 355
2018
Q3 		$8.85M Sell
46,443
-23,106
-33% -$4.24M 0.06% 254
2018
Q2 		$11.6M Buy
69,549
+8,887
+15% +$1.43M 0.08% 200
2018
Q1 		$10.2M Buy
60,662
+7,458
+14% +$1.25M 0.07% 230
2017
Q4 		$8.7M Buy
53,204
+15,262
+40% +$2.74M 0.06% 281
2017
Q3 		$7.78M Buy
37,942
+5,170
+16% +$1.2M 0.07% 274
2017
Q2 		$7.97M Sell
32,772
-1,992
-6% -$468K 0.08% 239
2017
Q1 		$8.31M Sell
34,764
-3,743
-10% -$872K 0.09% 216
2016
Q4 		$8.09M Buy
38,507
+5,555
+17% +$1.15M 0.09% 191
2016
Q3 		$7.59M Sell
32,952
-16,169
-33% -$3.95M 0.11% 154
2016
Q2 		$11.4M Sell
49,121
-2,734
-5% -$630K 0.15% 127
2016
Q1 		$13.9M Sell
51,855
-20,000
-28% -$5.73M 0.19% 118
2015
Q4 		$22.5M Buy
71,855
+3,524
+5% +$1.05M 0.27% 97
2015
Q3 		$18.6M Buy
68,331
+3,005
+5% +$923K 0.26% 94
2015
Q2 		$19.8M Sell
65,326
-8,420
-11% -$2.51M 0.27% 82
2015
Q1 		$21.9M Buy
73,746
+19,746
+37% +$5.63M 0.26% 79
2014
Q4 		$13.9M Buy
54,000
+8,795
+19% +$2.2M 0.16% 139
2014
Q3 		$10.9M Buy
45,205
+12,557
+38% +$2.81M 0.14% 129
2014
Q2 		$7.28M Sell
32,648
-3,544
-10% -$734K 0.09% 197
2014
Q1 		$7.45M Buy
36,192
+2,869
+9% +$568K 0.09% 185
2013
Q4 		$5.6M Buy
33,323
+20,226
+154% +$3.16M 0.08% 266
2013
Q3 		$1.89M Sell
13,097
-8,021
-38% -$1.07M 0.04% 440
2013
Q2 		$2.67M Buy
+21,118
New +$2.39M 0.05% 350

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ProShare Advisors's AGN Position: Q2 2020 in Review

ProShare Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 34,101 shares — an estimated $6.04M sold.

ProShare Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $22.5M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • ProShare Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • ProShare Advisors sold 34,101 Allergan plc shares in Q2 2020, an estimated $6.04M.
  • ProShare Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • ProShare Advisors's Allergan plc position peaked at $22.5M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.